Clinical trial
Use of NT-proBNP Testing to Guide Heart Failure Therapy in the Outpatient…
NCT00351390 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00351390 |
|---|---|
| Title | Use of NT-proBNP Testing to Guide Heart Failure Therapy in the Outpatient Setting. |
| Official title | The Use of Pro-Brain Natriuretic Peptide Targeted Therapy to Tailor Medical Management of Patients With Congestive Heart Failure Followed in an Outpatient Setting: the ProBNP Outpatient Tailored CHF Therapy (PROTECT) Study |
| Acronym | PROTECT |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Roche Diagnostics GmbH Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Congestive Heart Failure |
| Intervention type | Other |
| Interventions | Drug therapy for HF, NT-proBNP guided HF therapy |
| Enrollment | 152 |
| Start date | Sep 1, 2005 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Jul 12, 2006 |
| Last update posted | Mar 25, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: